Multimodality Imaging in Oncology
Corresponding author: [email protected]
Abstract
Multimodality imaging in oncology is the planned use of two or more imaging techniques, acquired separately or on a hybrid scanner, so that the anatomical and functional or molecular information each provides is combined to answer a clinical question about a cancer. The combination may be mental, as in reading a CT beside an MRI, software-based through registration and fusion, or hardware-based as in PET-CT, SPECT-CT and PET-MRI. The need for more than one modality follows from the physics: CT shows density and anatomy at high spatial resolution but cannot distinguish a normal-sized node containing tumour from an enlarged reactive node; MRI excels in soft tissue but is slow and motion-sensitive; PET reports metabolism or receptor expression at coarser resolution; ultrasound is real-time and free of ionising radiation but operator-dependent. This chapter covers imaging across the cancer-care continuum, the strengths and limits of each modality, hybrid imaging and fusion, tumour response criteria, preferred modality by tumour site, the multidisciplinary tumour board and the radiographer, radiomics and artificial intelligence, and the radiation burden of repeated imaging.
Author Affiliations
- 1 Scholar, Saraswati College of Pharmacy, SGC Group, Gharuan 140413, Mohali, Punjab, India.